{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:35:17Z","timestamp":1778031317008,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2011\/50292-2"],"award-info":[{"award-number":["2011\/50292-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research and Development from Fleury","award":["12619"],"award-info":[{"award-number":["12619"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["476356\/2008-3"],"award-info":[{"award-number":["476356\/2008-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306902\/2013-3"],"award-info":[{"award-number":["306902\/2013-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1443-5","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T06:58:43Z","timestamp":1508396323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Sandro F\u00e9lix","family":"Perazzio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Vitor","family":"Soeiro-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane Cardoso","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon Vilela","family":"de Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Salu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza Vilela","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Margherite","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Wagner Silva","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy R.","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Condino-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Eduardo Coelho","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"issue":"5 Suppl 24","key":"1443_CR1","first-page":"S6","volume":"19","author":"A G\u00fcl","year":"2001","unstructured":"G\u00fcl A. Beh\u00e7et\u2019s disease: an update on the pathogenesis. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S6\u201312.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1443_CR2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2011.04543.x","volume":"168","author":"J Shimizu","year":"2012","unstructured":"Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Suzuki N. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-\u03b3 in patients with Beh\u00e7et\u2019s disease. Clin Exp Immunol. 2012;168(1):68\u201374.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1443_CR3","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","volume":"38","author":"M Takeno","year":"1995","unstructured":"Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T. Excessive function of peripheral blood neutrophils from patients with Behcet\u2019s disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995;38(3):426\u201333.","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 24","key":"1443_CR4","first-page":"S19","volume":"19","author":"E Eksioglu-Demiralp","year":"2001","unstructured":"Eksioglu-Demiralp E, Direskeneli H, Kibaroglu A, Yavuz S, Ergun T, Akoglu T. Neutrophil activation in Behcet\u2019s disease. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S19\u201324.","journal-title":"Clin Exp Rheumatol"},{"issue":"4 Suppl 26","key":"1443_CR5","first-page":"S17","volume":"20","author":"G Atalay","year":"2002","unstructured":"Atalay G, Eksioglu-Demiralp E, Akoglu T, Direskeneli H. The effects of nitric oxide donors and inhibitors on neutrophil functions in Behcet\u2019s disease. Clin Exp Rheumatol. 2002;20(4 Suppl 26):S17\u201320.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1443_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1034\/j.1600-0463.2001.d01-111.x","volume":"109","author":"A Tekeli","year":"2001","unstructured":"Tekeli A, Tekeli O, Ozdemir O. In vitro candidacidal effect of polymorphonuclear neutrophils of Beh\u00e7et\u2019s patients with or without ocular involvement. APMIS. 2001;109(2):108\u201312.","journal-title":"APMIS"},{"issue":"9","key":"1443_CR7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","volume":"87","author":"DH Verity","year":"2003","unstructured":"Verity DH, Wallace GR, Vaughan RW, Stanford MR. Beh\u00e7et\u2019s disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87(9):1175\u201383.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1443_CR8","first-page":"1332","volume":"24","author":"A Carletto","year":"1997","unstructured":"Carletto A, Pacor ML, Biasi D, Caramaschi P, Zeminian S, Bellavite P, Bambara LM. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behcet\u2019s disease. J Rheumatol. 1997;24(7):1332\u20136.","journal-title":"J Rheumatol"},{"issue":"6 Suppl 94","key":"1443_CR9","first-page":"S85","volume":"33","author":"SF Perazzio","year":"2015","unstructured":"Perazzio SF, Soeiro-Pereira PV, de Souza AW, Condino-Neto A, Andrade LE. Beh\u00e7et\u2019s disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations. Clin Exp Rheumatol. 2015;33(6 Suppl 94):S85\u201395.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"1443_CR10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-009-1261-5","volume":"28","author":"FS Neves","year":"2009","unstructured":"Neves FS, Carrasco S, Goldenstein-Schainberg C, Goncalves CR, de Mello SB. Neutrophil hyperchemotaxis in Behcet\u2019s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses. Clin Rheumatol. 2009;28(12):1403\u201310.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1443_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/10715769809097874","volume":"28","author":"T Yoshida","year":"1998","unstructured":"Yoshida T, Tanaka M, Sotomatsu A, Okamoto K, Hirai S. Serum of Behcet\u2019s disease enhances superoxide production of normal neutrophils. Free Radic Res. 1998;28(1):39\u201344.","journal-title":"Free Radic Res"},{"issue":"11","key":"1443_CR12","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1074\/jbc.271.11.5965","volume":"271","author":"F Pietravalle","year":"1996","unstructured":"Pietravalle F, Lecoanet-Henchoz S, Blasey H, Aubry JP, Elson G, Edgerton MD, Bonnefoy JY, Gauchat JF. Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem. 1996;271(11):5965\u20137.","journal-title":"J Biol Chem"},{"issue":"5","key":"1443_CR13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.imbio.2011.03.010","volume":"217","author":"GS Hassan","year":"2012","unstructured":"Hassan GS, Merhi Y, Mourad W. CD40 ligand: a neo-inflammatory molecule in vascular diseases. Immunobiology. 2012;217(5):521\u201332.","journal-title":"Immunobiology"},{"issue":"1","key":"1443_CR14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH11-08-0556","volume":"107","author":"I Fern\u00e1ndez Bello","year":"2012","unstructured":"Fern\u00e1ndez Bello I, \u00c1lvarez MT, L\u00f3pez-Longo FJ, Arias-Salgado EG, Mart\u00edn M, Jim\u00e9nez-Yuste V, de la R\u00faa Rodr\u00edguez A, Butta NV. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Beh\u00e7et disease patients. Thromb Haemost. 2012;107(1):88\u201398.","journal-title":"Thromb Haemost"},{"issue":"6","key":"1443_CR15","doi-asserted-by":"crossref","first-page":"e64631","DOI":"10.1371\/journal.pone.0064631","volume":"8","author":"R Jin","year":"2013","unstructured":"Jin R, Yu S, Song Z, Zhu X, Wang C, Yan J, Wu F, Nanda A, Granger DN, Li G. Soluble CD40 ligand stimulates CD40-dependent activation of the \u03b22 integrin Mac-1 and protein kinase C zeda (PKC\u03b6) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst. PLoS One. 2013;8(6):e64631.","journal-title":"PLoS One"},{"issue":"6","key":"1443_CR16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140(6):784\u201390.","journal-title":"Cell"},{"issue":"8697","key":"1443_CR17","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet"},{"issue":"1","key":"1443_CR18","first-page":"20","volume":"49","author":"NF Souza de","year":"2009","unstructured":"de Souza NF, Muniz Caldas CA, de Martins Medeiros D, de Bertacini Moraes JC, Gon\u00e7alves CR. Cross-cultural adaptation of simplified version(s) of Beh\u00e7et\u2019s Disease Current Activity Form (BDCAF) and comparison between two different instruments with Brazilian versions for evaluating Beh\u00e7et\u2019s Disease Activity: BR-BDCAF and BR-BDCAF(s) [in Portuguese]. Rev Bras Reumatol. 2009;49(1):20\u201331.","journal-title":"Rev Bras Reumatol"},{"issue":"6","key":"1443_CR19","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ, ACCP\/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644\u201355.","journal-title":"Chest"},{"issue":"9","key":"1443_CR20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1443_CR21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1443_CR22","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1476-5381.2011.01764.x","volume":"166","author":"PV Soeiro-Pereira","year":"2012","unstructured":"Soeiro-Pereira PV, Falcai A, Kubo CA, Oliveira-J\u00fanior EB, Marques OC, Antunes E, Condino-Neto A. BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes. Br J Pharmacol. 2012;166(5):1617\u201330.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"1443_CR23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.freeradbiomed.2006.06.014","volume":"41","author":"E Hatanaka","year":"2006","unstructured":"Hatanaka E, Levada-Pires AC, Pithon-Curi TC, Curi R. Systematic study on ROS production induced by oleic, linoleic, and gamma-linolenic acids in human and rat neutrophils. Free Radic Biol Med. 2006;41(7):1124\u201332.","journal-title":"Free Radic Biol Med"},{"key":"1443_CR24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jim.2015.03.018","volume":"423","author":"O Maguire","year":"2015","unstructured":"Maguire O, O\u2019Loughlin K, Minderman H. Simultaneous assessment of NF-\u03baB\/p65 phosphorylation and nuclear localization using imaging flow cytometry. J Immunol Methods. 2015;423:3\u201311.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1443_CR25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231\u201341.","journal-title":"J Cell Biol"},{"issue":"2","key":"1443_CR26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10875-011-9623-6","volume":"32","author":"O Cabral-Marques","year":"2012","unstructured":"Cabral-Marques O, Schimke LF, Pereira PV, Falcai A, de Oliveira JB, Hackett MJ, Errante PR, Weber CW, Ferreira JF, Kuntze G, et al. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of paracoccidioidomycosis and other unusual infections in Brazilian patients. J Clin Immunol. 2012;32(2):212\u201320.","journal-title":"J Clin Immunol"},{"issue":"9","key":"1443_CR27","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1172\/JCI118643","volume":"97","author":"A Desai-Mehta","year":"1996","unstructured":"Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest. 1996;97(9):2063\u201373.","journal-title":"J Clin Invest"},{"issue":"1","key":"1443_CR28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/clim.2001.5172","volume":"103","author":"CG Katsiari","year":"2002","unstructured":"Katsiari CG, Liossis SN, Souliotis VL, Dimopoulos AM, Manoussakis MN, Sfikakis PP. Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin Immunol. 2002;103(1):54\u201362.","journal-title":"Clin Immunol"},{"issue":"4","key":"1443_CR29","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/CIRCRESAHA.114.305930","volume":"116","author":"R Lee","year":"2015","unstructured":"Lee R. Revisiting the role of sCD40L as an inflammatory biomarker in a clinical model of acute myocardial infarction. Circ Res. 2015;116(4):e26.","journal-title":"Circ Res"},{"issue":"7","key":"1443_CR30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1179\/1743132813Y.0000000190","volume":"35","author":"JH Wang","year":"2013","unstructured":"Wang JH, Zhang YW, Zhang P, Deng BQ, Ding S, Wang ZK, Wu T, Wang J. CD40 ligand as a potential biomarker for atherosclerotic instability. Neurol Res. 2013;35(7):693\u2013700.","journal-title":"Neurol Res"},{"issue":"6","key":"1443_CR31","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1160\/TH16-06-0471","volume":"116","author":"F Santilli","year":"2016","unstructured":"Santilli F, Liani R, Di Fulvio P, Formoso G, Simeone P, Tripaldi R, Ueland T, Aukrust P, Dav\u00ec G. Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus. Thromb Haemost. 2016;116(6):1089\u201399.","journal-title":"Thromb Haemost"},{"issue":"9","key":"1443_CR32","first-page":"1544","volume":"20","author":"JL Mege","year":"1993","unstructured":"Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inan\u00e7 M, Capo C. Overproduction of monocyte derived tumor necrosis factor \u03b1, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et\u2019s disease: a comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20(9):1544\u20139.","journal-title":"J Rheumatol"},{"issue":"5","key":"1443_CR33","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar2833","volume":"11","author":"J Sellam","year":"2009","unstructured":"Sellam J, Proulle V, J\u00fcngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, et al. Increased levels of circulating microparticles in primary Sj\u00f6gren\u2019s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther. 2009;11(5):R156.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1443_CR34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09537100701210057","volume":"19","author":"GE Pamuk","year":"2008","unstructured":"Pamuk GE, Vural O, Turgut B, Demir M, Pamuk ON, Cakir N. Increased platelet activation markers in rheumatoid arthritis: are they related with subclinical atherosclerosis? Platelets. 2008;19(2):146\u201354.","journal-title":"Platelets"},{"issue":"3","key":"1443_CR35","first-page":"514","volume":"31","author":"K Komura","year":"2004","unstructured":"Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol. 2004;31(3):514\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"1443_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10067-002-0669-y","volume":"22","author":"M Jinnin","year":"2003","unstructured":"Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Elevated circulating soluble CD40 ligand in patients with mixed connective tissue disease. Clin Rheumatol. 2003;22(1):37\u20139.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1443_CR37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10067-006-0389-9","volume":"26","author":"H Cifersk\u00e1","year":"2007","unstructured":"Cifersk\u00e1 H, Hor\u00e1k P, Hermanov\u00e1 Z, Ordeltov\u00e1 M, Zadrazil J, Tich\u00fd T, Scudla V. The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value. Clin Rheumatol. 2007;26(5):723\u20138.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1443_CR38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/SLA.0b013e3181bd95b7","volume":"250","author":"M Rahman","year":"2009","unstructured":"Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H. Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Ann Surg. 2009;250(5):783\u201390.","journal-title":"Ann Surg"},{"issue":"21","key":"1443_CR39","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107(21):9813\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1443_CR40","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar4579","volume":"16","author":"C Sur Chowdhury","year":"2014","unstructured":"Sur Chowdhury C, Giaglis S, Walker UA, Buser A, Hahn S, Hasler P. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther. 2014;16(3):R122.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1443_CR41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1681\/ASN.2013060606","volume":"25","author":"D Nakazawa","year":"2014","unstructured":"Nakazawa D, Shida H, Tomaru U, Yoshida M, Nishio S, Atsumi T, Ishizu A. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J Am Soc Nephrol. 2014;25(5):990\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"1443_CR42","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2013-04-457671","volume":"122","author":"BG Yipp","year":"2013","unstructured":"Yipp BG, Kubes P. NETosis: how vital is it? Blood. 2013;122(16):2784\u201394.","journal-title":"Blood"},{"issue":"9","key":"1443_CR43","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.4049\/jimmunol.1303239","volume":"192","author":"JH Xie","year":"2014","unstructured":"Xie JH, Yamniuk AP, Borowski V, Kuhn R, Susulic V, Rex-Rabe S, Yang X, Zhou X, Zhang Y, Gillooly K, et al. Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases. J Immunol. 2014;192(9):4083\u201392.","journal-title":"J Immunol"},{"issue":"10","key":"1443_CR44","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/0961203315574558","volume":"24","author":"A Tocoian","year":"2015","unstructured":"Tocoian A, Buchan P, Kirby H, Soranson J, Zamacona M, Walley R, Mitchell N, Esfandiari E, Wagner F, Oliver R. First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus. Lupus. 2015;24(10):1045\u201356.","journal-title":"Lupus"},{"issue":"10","key":"1443_CR45","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1600-6143.2008.02372.x","volume":"8","author":"SC Wood","year":"2008","unstructured":"Wood SC, Lu G, Burrell BE, Bishop DK. Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells. Am J Transplant. 2008;8(10):2037\u201348.","journal-title":"Am J Transplant"},{"issue":"4","key":"1443_CR46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2008.07039.x","volume":"141","author":"VL Patel","year":"2008","unstructured":"Patel VL, Schwartz J, Bussel JB. The effect of anti-CD40 ligand in immune thrombocytopenic purpura. Br J Haematol. 2008;141(4):545\u20138.","journal-title":"Br J Haematol"},{"issue":"3","key":"1443_CR47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000068888","volume":"206","author":"E Alpsoy","year":"2003","unstructured":"Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis CC. Serum of patients with Behcet\u2019s disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology. 2003;206(3):225\u201332.","journal-title":"Dermatology"},{"issue":"6","key":"1443_CR48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s004030000128","volume":"292","author":"CC Zouboulis","year":"2000","unstructured":"Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE. Adamantiades-Behcet\u2019s disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res. 2000;292(6):279\u201384.","journal-title":"Arch Dermatol Res"},{"issue":"5 Suppl 24","key":"1443_CR49","first-page":"S37","volume":"19","author":"I Ertenli","year":"2001","unstructured":"Ertenli I, Kiraz S, Calguneri M, Celik I, Erman M, Haznedaroglu IC, Kirazli S. Synovial fluid cytokine levels in Behcet\u2019s disease. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S37\u201341.","journal-title":"Clin Exp Rheumatol"},{"issue":"7081","key":"1443_CR50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"issue":"19","key":"1443_CR51","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1016\/j.yexcr.2009.08.020","volume":"315","author":"RW Jackman","year":"2009","unstructured":"Jackman RW, Rhoads MG, Cornwell E, Kandarian SC. Microtubule-mediated NF-\u03baB activation in the TNF-\u03b1 signaling pathway. Exp Cell Res. 2009;315(19):3242\u20139.","journal-title":"Exp Cell Res"},{"issue":"6","key":"1443_CR52","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","volume":"153","author":"EW Chia","year":"2008","unstructured":"Chia EW, Grainger R, Harper JL. Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine. Br J Pharmacol. 2008;153(6):1288\u201395.","journal-title":"Br J Pharmacol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1443-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T06:58:56Z","timestamp":1508396336000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1443-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1443-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]},"article-number":"235"}}